Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1
Jielin Zhang, … , David T. Scadden, Clyde S. Crumpacker
Jielin Zhang, … , David T. Scadden, Clyde S. Crumpacker
Published February 1, 2007
Citation Information: J Clin Invest. 2007;117(2):473-481. https://doi.org/10.1172/JCI28971.
View: Text | PDF
Research Article Article has an altmetric score of 10

Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1

  • Text
  • PDF
Abstract

Hematopoietic stem cells are resistant to HIV-1 infection. Here, we report a novel mechanism by which the cyclin-dependent kinase inhibitor (CKI) p21Waf1/Cip1/Sdi1 (p21), a known regulator of stem cell pool size, restricts HIV-1 infection of primitive hematopoietic cells. Modifying p21 expression altered HIV-1 infection prior to changes in cell cycling and was selective for p21 since silencing the related CKIs, p27Kip1 and p18INK4C, had no effect on HIV-1. We show that p21 blocked viral infection by complexing with HIV-1 integrase and aborting chromosomal integration. A closely related lentivirus with a distinct integrase, SIVmac-251, and the other cell-intrinsic inhibitors of HIV-1, Trim5α, PML, Murr1, and IFN-α, were unaffected by p21. Therefore, p21 is an endogenous cellular component in stem cells that provides a unique molecular barrier to HIV-1 infection and may explain how these cells remain an uninfected “sanctuary” in HIV disease.

Authors

Jielin Zhang, David T. Scadden, Clyde S. Crumpacker

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 6 1 1 1 2 4 4 2 6 6 6 5 11 7 12 4 2 81
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (81)

Title and authors Publication Year
Gaining momentum: stem cell therapies for HIV cure
Buck AM, LaFranchi BH, Henrich TJ
Current Opinion in HIV and AIDS 2024
Role of MXRA8 in Ross River Virus Disease Pathogenesis
Ng WH, Ling ZL, Kueh AJ, Herold MJ, West NP, King NJ, Mahalingam S, Liu X
mBio 2023
Consequences of HIV infection in the bone marrow niche
Herd CL, Mellet J, Mashingaidze T, Durandt C, Pepper MS
Frontiers in immunology 2023
Molecular dynamics of genome editing with CRISPR-Cas9 and rAAV6 virus in human HSPCs to treat sickle cell disease
Xu L, Lahiri P, Skowronski J, Bhatia N, Lattanzi A, Porteus MH
2023
The Role of p53 in HIV Infection.
Yaseen MM, Abuharfeil NM, Darmani H
Current HIV/AIDS Reports 2023
Approaches to pandemic prevention – the chromatin vaccine
Zhang J, Askenase P, Jaenisch R, Crumpacker CS
Frontiers in immunology 2023
Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection.
Linkner TR, Ambrus V, Kunkli B, Szojka ZI, Kalló G, Csősz É, Kumar A, Emri M, Tőzsér J, Mahdi M
International journal of molecular sciences 2023
HIV UTR, LTR, and Epigenetic Immunity
Zhang J, Crumpacker C
Viruses 2022
Predicted Cellular Interactors of the Endogenous Retrovirus-K Integrase Enzyme
I Benoit, S Brownell, RN Douville
Microorganisms 2021
Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP1
SS de Azevedo, M Ribeiro-Alves, FH Côrtes, E Delatorre, L Spangenberg, H Naya, LN Seito, B Hoagland, B Grinsztejn, VG Veloso, MG Morgado, TM Souza, G Bello
Retrovirology 2020
Role of platelet-derived microparticles in transfer of the chemokine receptor CXCR4 to CXCR4-negative cells
Tahereh Manoochehrabadi, Zohreh Sharifi, Fatemeh Yari
Medical journal of the Islamic Republic of Iran 2019
Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes
S Ozog, ND Timberlake, K Hermann, O Garijo, KG Haworth, G Shi, CM Glinkerman, LE Schefter, S DSouza, E Simpson, G Sghia-Hughes, RR Carillo, DL Boger, HP Kiem, I Slukvin, BY Ryu, BP Sorrentino, JE Adair, SA Snyder, AA Compton, BE Torbett
Blood 2019
HIV-1 Vpr and p21 restrict LINE-1 mobility
K Kawano, AJ Doucet, M Ueno, R Kariya, W An, F Marzetta, M Kuroki, P Turelli, S Sukegawa, S Okada, K Strebel, D Trono, Y Ariumi
Nucleic Acids Research 2018
Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production
N Höti, T Johnson, W Chowdhury, R Rodriguez
Cancers 2018
Inhibition of HIV early replication by the p53 and its downstream gene p21
B Shi, HJ Sharifi, S DiGrigoli, M Kinnetz, K Mellon, W Hu, CM de Noronha
Virology Journal 2018
Prostaglandin E 2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells
GC Heffner, M Bonner, L Christiansen, FJ Pierciey, D Campbell, Y Smurnyy, W Zhang, A Hamel, S Shaw, G Lewis, KA Goss, O Garijo, BE Torbett, H Horton, MH Finer, PD Gregory, G Veres
Molecular Therapy 2018
Underlying mechanisms of HIV-1 latency
B Romani, E Allahbakhshi
Virus Genes 2017
T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
S Bolduan, H Koppensteiner, R Businger, S Rebensburg, C Kunze, R Brack-Werner, R Draenert, M Schindler
Journal of the International AIDS Society 2017
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
F Piras, M Riba, C Petrillo, D Lazarevic, I Cuccovillo, S Bartolaccini, E Stupka, B Gentner, D Cittaro, L Naldini, A KajasteRudnitski
EMBO Molecular Medicine 2017
Toward a Cure: Does Host Immunity Play a Role?
J Zhang, CS Crumpacker, MJ Imperiale
mSphere 2017
Restriction of HIV-1-based lentiviral vectors in adult primary marrow-derived and peripheral mobilized human CD34+ hematopoietic stem and progenitor cells occurs prior to viral DNA integration
DO Griffin, SP Goff
Retrovirology 2016
Current views on HIV-1 latency, persistence, and cure
Z Melkova, P Shankaran, M Madlenakova, J Bodor
Folia Microbiologica 2016
Potential Implication of Residual Viremia in Patients on Effective Antiretroviral Therapy
GK Sahu
AIDS Research and Human Retroviruses 2015
Select host restriction factors are associated with HIV persistence during antiretroviral therapy:
M Abdel-Mohsen, C Wang, MC Strain, SM Lada, X Deng, LR Cockerham, CD Pilcher, FM Hecht, T Liegler, DD Richman, SG Deeks, SK Pillai
AIDS 2015
T Memory Stem Cells and HIV: a Long-Term Relationship
A Chahroudi, G Silvestri, M Lichterfeld
Current HIV/AIDS Reports 2015
p21WAF1/CIP1 RNA Expression in Highly HIV-1 Exposed, Uninfected Individuals
J Herbeck, S Ghorai, L Chen, CR Rinaldo, JB Margolick, R Detels, L Jacobson, S Wolinsky, JI Mullins, CM Gray
PloS one 2015
HIV-1 Is Restricted prior to Integration of Viral DNA in Primary Cord-Derived Human CD34 + Cells
DO Griffin, SP Goff, KL Beemon
Journal of virology 2015
Hematopoietic Stem and Immune Cells in Chronic HIV Infection
J Zhang, C Crumpacker
Stem Cells International 2015
Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells
CX Wang, BD Sather, X Wang, J Adair, I Khan, S Singh, S Lang, A Adams, G Curinga, HP Kiem, CH Miao, DJ Rawlings, BE Torbett
Blood 2014
A Cell-Intrinsic Inhibitor of HIV-1 Reverse Transcription in CD4+ T Cells from Elite Controllers
J Leng, HP Ho, MJ Buzon, F Pereyra, BD Walker, XG Yu, EJ Chang, M Lichterfeld
Cell Host & Microbe 2014
Alteration of select gene expression patterns in individuals infected with HIV-1: Gene Expression Altered by HIV
E Serrao, CH Wang, T Frederick, CL Lee, P Anthony, D Arribas-Layton, K Baker, J Millstein, A Kovacs, N Neamati
Journal of Medical Virology 2014
Cyclosporin A and Rapamycin Relieve Distinct Lentiviral Restriction Blocks in Hematopoietic Stem and Progenitor Cells
C Petrillo, D Cesana, F Piras, S Bartolaccini, L Naldini, E Montini, A Kajaste-Rudnitski
Molecular Therapy 2014
COMMD1/Murr1 Reinforces HIV-1 Latent Infection through IκB-α Stabilization
M Taura, E Kudo, R Kariya, H Goto, K Matsuda, S Hattori, K Vaeteewoottacharn, F McDonald, MA Suico, T Shuto, H Kai, S Okada, F Kirchhoff
Journal of virology 2014
Making sense of how HIV kills infected CD4 T cells: implications for HIV cure
NW Cummins, AD Badley
Molecular and Cellular Therapies 2014
p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway
A Allouch, A David, SM Amie, H Lahouassa, L Chartier, F Margottin-Goguet, F Barré-Sinoussi, B Kim, A Sáez-Cirión, G Pancino
Proceedings of the National Academy of Sciences 2013
Concurrent Measures of Fusion and Transduction Efficiency of Primary CD34+ Cells with Human Immunodeficiency Virus 1-Based Lentiviral Vectors Reveal Different Effects of Transduction Enhancers
D Ingrao, S Majdoul, AK Seye, A Galy, D Fenard
Human Gene Therapy Methods 2013
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages
D Gibellini, A Clò, S Morini, A Miserocchi, C Ponti, MC Re
World Journal of Virology 2013
Eradication of HIV and Cure of AIDS, Now and How?
J Zhang, C Crumpacker
Frontiers in immunology 2013
Expression profile of host restriction factors in HIV-1 elite controllers
M Abdel-Mohsen, RA Raposo, X Deng, M Li, T Liegler, E Sinclair, MS Salama, HE Ghanem, R Hoh, JK Wong, M David, DF Nixon, SG Deeks, SK Pillai
Retrovirology 2013
Design of Cell-Permeable Stapled Peptides as HIV-1 Integrase Inhibitors
YQ Long, SX Huang, Z Zawahir, ZL Xu, H Li, TW Sanchez, Y Zhi, SD Houwer, F Christ, Z Debyser, N Neamati
Journal of Medicinal Chemistry 2013
Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
S Elahi, T Niki, M Hirashima, H Horton
Blood 2012
Associations between HIV and Human Pathways Revealed by Protein-Protein Interactions and Correlated Gene Expression Profiles
KC Chen, TY Wang, C Chan
PloS one 2012
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
H Koppensteiner, R Brack-Werner, M Schindler
Retrovirology 2012
Short Communication: Colony-Forming Hematopoietic Progenitor Cells Are Not Preferentially Infected by HIV Type 1 Subtypes A and D in Vivo
CE Mullis, AE Oliver, LA Eller, D Guwatudde, AC Mueller, MA Eller, H Kibuuka, M Robb, TC Quinn, AD Redd
AIDS Research and Human Retroviruses 2012
HIV-1 Pathogenesis: The Virus
R Swanstrom, J Coffin
Cold Spring Harbor Perspectives in Medicine 2012
CD4 T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 (cip-1/waf-1)
Huabiao Chen, Chun Li, Jinghe Huang, Thai Cung, Katherine Seiss, Jill Beamon, Mary Carrington, Lindsay Porter, Patrick Burke, Yue Yang, Bethany Ryan, Ruiwu Liu, Robert H. Weiss, Florencia Pereyra, W. Douglas Cress, Abraham Brass, Eric Rosenberg, Bruce D. Walker, Xu Yu, Mathias Lichterfeld
Journal of Clinical Investigation 2011
Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages
R Shen, G Meng, C Ochsenbauer, PR Clapham, J Grams, L Novak, JC Kappes, LE Smythies, PD Smith
PLoS pathogens 2011
Latent HIV-1 Infection of Resting CD4+ T Cells in the Humanized Rag2−/− γc−/− Mouse
SK Choudhary, NM Archin, M Cheema, NP Dahl, JV Garcia, DM Margolis
Journal of virology 2011
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages
SM Bol, PD Moerland, S Limou, Y Remmerden, C Coulonges, D Manen, JT Herbeck, J Fellay, M Sieberer, JG Sietzema, R Slot, J Martinson, JF Zagury, H Schuitemaker, AB van Wout
PloS one 2011
Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon
T Pertel, C Reinhard, J Luban
Retrovirology 2011
HIV-1 Utilizes the CXCR4 Chemokine Receptor to Infect Multipotent Hematopoietic Stem and Progenitor Cells
CC Carter, LA McNamara, A Onafuwa-Nuga, M Shackleton, JR 4th, D Bixby, MR Savona, SJ Morrison, KL Collins
Cell Host & Microbe 2011
The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for β-Thalassemia
E Drakopoulou, E Papanikolaou, NP Anagnou
Stem Cells International 2011
A whole genome screen for HIV restriction factors
L Liu, NM Oliveira, KM Cheney, C Pade, H Dreja, AM Bergin, V Borgdorff, DH Beach, CL Bishop, MT Dittmar, A McKnight
Retrovirology 2011
EFFECTS OF HIV-1 GP120 AND PROTEASE INHIBITORS ON APOPTOTIC SUSCEPTIBILITY OF CD34+ HEMATOPOIETIC PROGENITOR CELLS
OJ MacEneaney, E Connick, CA DeSouza
Journal of acquired immune deficiency syndromes (1999) 2011
Inhibition of HIV-1 Integration in Ex Vivo-Infected CD4 T Cells from Elite Controllers
MJ Buzon, K Seiss, R Weiss, AL Brass, ES Rosenberg, F Pereyra, XG Yu, M Lichterfeld
Journal of virology 2011
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers
Sáez-Cirión A, Hamimi C, Bergamaschi A, David A, Versmisse P, Mélard A, Boufassa F, Barré-Sinoussi F, Lambotte O, Rouzioux C, Pancino G
Blood 2011
Host hindrance to HIV-1 replication in monocytes and macrophages
A Bergamaschi, G Pancino
Retrovirology 2010
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs
CC Carter, A Onafuwa-Nuga, LA McNamara, JR 4th, D Bixby, MR Savona, KL Collins
Nature Medicine 2010
Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein
A Levin, Z Hayouka, A Friedler, A Loyter
Nucleus (Austin, Tex.) 2010
Human T-lymphotropic virus type 1 transcription and chromatin-remodeling complexes
R Easley, L Carpio, I Guendel, Z Klase, S Choi, K Kehn-Hall, JN Brady, F Kashanchi
Journal of virology 2010
Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes
L Manganaro, M Lusic, MI Gutierrez, A Cereseto, GD Sal, M Giacca
Nature Medicine 2010
Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells
A Levin, Z Hayouka, A Friedler, A Loyter
Nucleus 2010
Inducible APOBEC3G-Vif Double Stable Cell Line as a High-Throughput Screening Platform To Identify Antiviral Compounds
B Nowotny, T Schneider, G Pradel, T Schirmeister, A Rethwilm, M Kirschner
Antimicrobial agents and chemotherapy 2010
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo
C Goffinet, I Allespach, L Oberbremer, PL Golden, SA Foster, BA Johns, JG Weatherhead, SJ Novick, KE Chiswell, EP Garvey, OT Keppler
Journal of virology 2009
HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis
KC Williams, TH Burdo
APMIS 2009
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
M Coiras, MR López-Huertas, M Pérez-Olmeda, J Alcamí
Nature Reviews Microbiology 2009
Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration
A Levin, Z Hayouka, R Brack-Werner, DJ Volsky, A Friedler, A Loyter
Protein engineering, design & selection : PEDS 2009
Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins
A Levin, J Rosenbluh, Z Hayouka, A Friedler, A Loyter
Molecular Medicine 2009
The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages
A Bergamaschi, A David, EL Rouzic, S Nisole, F Barré-Sinoussi, G Pancino
Journal of virology 2009
Novel HIV-1 therapeutics through targeting altered host cell pathways
W Coley, K Kehn-Hall, RV Duyne, F Kashanchi
Expert Opinion on Biological Therapy 2009
The brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection
J Haedicke, C Brown, MH Naghavi
Proceedings of the National Academy of Sciences 2009
9-Aminoacridine inhibition of HIV-1 Tat dependent transcription
I Guendel, L Carpio, R Easley, RV Duyne, W Coley, E Agbottah, C Dowd, F Kashanchi, K Kehn-Hall
Virology Journal 2009
RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses
M Shiina, MD Lacher, C Christian, WM Korn
Cancer Gene Therapy 2009
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
T Cherrier, S Suzanne, L Redel, M Calao, C Marban, B Samah, R Mukerjee, C Schwartz, G Gras, BE Sawaya, SL Zeichner, D Aunis, CV Lint, O Rohr
Oncogene 2009
Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal
A Levin, A Armon-Omer, J Rosenbluh, N Melamed-Book, A Graessmann, E Waigmann, A Loyter
Retrovirology 2009
Is Nef the elusive cause of HIV-associated hematopoietic dysfunction?
Frank Kirchhoff1 and Guido Silvestri2
Journal of Clinical Investigation 2008
Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration
HM Tervo, C Goffinet, OT Keppler
Retrovirology 2008
Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation
W Wu, K Kehn-Hall, C Pedati, L Zweier, I Castro, Z Klase, CS Dowd, L Dubrovsky, M Bukrinsky, F Kashanchi
Virology Journal 2008
The Ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infection
J Haedicke, KL los Santos, SP Goff, MH Naghavi
Journal of virology 2008
An intrinsic host defense against HIV-1 integration?
Paul D. Bieniasz
Journal of Clinical Investigation 2007
Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa
AD Redd, A Avalos, M Essex
Blood 2007

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 2 patents
Referenced in 6 Wikipedia pages
67 readers on Mendeley
See more details